Evidence map›Paper›PMID 29500902›Full record

ArticleCytoskeleton (Hoboken, N.J.)2018

Distinct sites in tropomyosin specify shared and isoform-specific regulation of myosins II and V.

Bipasha Barua, Maria Sckolnick, Howard D White, Kathleen M Trybus, Sarah E Hitchcock-DeGregori

Abstract read
In one paragraph

Article in Cytoskeleton (Hoboken, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Bipasha BaruaDepartment of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey 08854.
Maria SckolnickDepartment of Molecular Physiology, Biophysics University of Vermont, Burlington, Vermont 05405.
Howard D WhiteDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia 23507.
Kathleen M TrybusDepartment of Molecular Physiology, Biophysics University of Vermont, Burlington, Vermont 05405.
Sarah E Hitchcock-DeGregoriDepartment of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey 08854.
American Heart Association · USEastern Virginia Medical School · USFoundation for the National Institutes of Health · USJohnson University · USUniversity of Vermont · US

Funding

MUTATIONAL STUDIES OF PROCESSIVE MYOSIN MOTORSR01GM078097 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TRYBUS, KATHLEEN M · 2007 to 2019
$4.8M
Deciphering how tropomyosin regulates the actin filamentR01GM093065 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI HITCHCOCK-DEGREGORI, SARAH ELLEN · 2010 to 2013
$1.2M
NIGMS NIH HHS R01 GM078097NIGMS NIH HHS R01 GM093065
6 · The paper itself

Abstract

Muscle contraction, cytokinesis, cellular movement, and intracellular transport depend on regulated actin-myosin interaction. Most actin filaments bind one or more isoform of tropomyosin, a coiled-coil protein that stabilizes the filaments and regulates interactions with other actin-binding proteins, including myosin. Isoform-specific allosteric regulation of muscle myosin II by actin-tropomyosin is well-established while that of processive myosins, such as myosin V, which transport organelles and macromolecules in the cell periphery, is less certain. Is the regulation by tropomyosin a universal mechanism, the consequence of the conserved periodic structures of tropomyosin, or is it the result of specialized interactions between particular isoforms of myosin and tropomyosin? Here, we show that striated muscle tropomyosin, Tpm1.1, inhibits fast skeletal muscle myosin II but not myosin Va. The non-muscle tropomyosin, Tpm3.1, in contrast, activates both myosins. To decipher the molecular basis of these opposing regulatory effects, we introduced mutations at conserved surface residues within the six periodic repeats (periods) of Tpm3.1, in positions homologous or analogous to those important for regulation of skeletal muscle myosin by Tpm1.1. We identified conserved residues in the internal periods of both tropomyosin isoforms that are important for the function of myosin Va and striated myosin II. Conserved residues in the internal and C-terminal periods that correspond to Tpm3.1-specific exons inhibit myosin Va but not myosin II function. These results suggest that tropomyosins may directly impact myosin function through both general and isoform-specific mechanisms that identify actin tracks for the recruitment and function of particular myosins.

Indexed as

Cell MovementActinsAmino Acid SequenceAnimalsChickensMiceMyosin Type IIMyosin Type VProtein BindingProtein ConformationProtein IsoformsRatsSequence HomologyTropomyosinActinsMyosin Type IIMyosin Type VProtein IsoformsTropomyosinactin cytoskeletonactomyosin regulationcoiled coilintracellular transportmuscle contraction

Identifiers

PMID29500902
PMCPMC5899941
OpenAlexW2789891048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.